Cynthia Rothblum-Oviatt's schedule for DIA 2025 Global Annual Meeting

Cynthia Rothblum-Oviatt

FDA

Science Policy Analyst, Rare Disease Team, OND, CDER

PhD scientist with more than 20 years experience in the rare disease space. External Engagement Lead for CDER's Rare Diseases Team.